Japan’s Kobayashi Pharma yet to find cause of supplement deaths
-
Kobayashi Pharmaceutical President Akihiro Kobayashi, center, apologizes
for the supplement scandal at a news conference on March 29. (Photo by Yo
Inoue) |...
21 minutes ago
Yalor. When one door closed; another waiting to be opened. Let see how Mr Market react?
ReplyDeleteSGX finds new index partner in FTSE Russell as battle for index business heats up
JUST barely three months after long-term partner MSCI Inc said it would migrate from Singapore to Hong Kong licensing for derivatives products on a host of gauges, Singapore Exchange (SGX) has found a new beau in rival index provider, FTSE Russell, to deliver new Asian multi-asset solutions.
On Thursday, SGX said it would build on its long relationship and track record in existing products with London Stock Exchange-owned FTSE to develop and market a multi-asset index derivatives offering focusing on Asian and Emerging Markets.
In the coming months, SGX and FTSE Russell will roll out products to meet the needs of global investors.